Saltar al contenido
Merck

Salivary biomarkers, vital signs and behaviour of pre-school children during their first dental visit.

European journal of paediatric dentistry : official journal of European Academy of Paediatric Dentistry (2013-12-10)
S S Rodrigues Gomes, A C Barretobezerra, A C Maia Prado
RESUMEN

Anxiety may influence dental treatment unfavourably, thus evaluation of the psychophysiological reactions of the child may reduce its negative effects. This study aimed to evaluate and correlate the levels of cortisol and alpha-amylase, vital signs and behaviour of children during their first dental visit. Study sample consisted of 32 children (11 male and 21 female patients) aged between 4 and 6 years, who would go to the dentist for the first time, with no pain or chronic illness, and without the use of medication. Three saliva samples were collected: before, immediately after and 20 minutes after the dental procedure (dental prophylaxis). Data were analysed using Student's t test and Pearson's correlation test (p = 0.05). In the comparison of the levels of alpha-amylase, the heart rate and blood pressure were higher after the dental visit and the levels of salivary cortisol were significantly higher before. There was no statistically significant difference in the correlation between the Frankl Behaviour Rating Scale and the levels of cortisol and alpha-amylase, but the results showed that the levels of these two salivary biomarkers increased gradually as the child had a less cooperative behaviour. CONCLUSION The sample revealed that the first dental visit generated anxiety, which was manifested through physiological and behavioural alterations.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
αα-Amilasa termoestable, solution, for use in Total Dietary Fiber Assay, TDF-100A
Sigma-Aldrich
Hydrocortisone, BioReagent, suitable for cell culture
Sigma-Aldrich
Hydrocortisone solution, 50 μM, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
αα-Amilasa from human saliva, Type XIII-A, lyophilized powder, 300-1,500 units/mg protein
Sigma-Aldrich
α-Amylase from porcine pancreas, Type VI-B, ≥5 units/mg solid
Sigma-Aldrich
Hydrocortisone, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Hydrocortisone, ≥98% (HPLC)
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, powder, ~30 U/mg
Sigma-Aldrich
Taka-diastasa from Aspergillus oryzae, powder, slightly beige, ~100 U/mg
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, ≥150 units/mg protein (biuret)
Sigma-Aldrich
αα-Amilasa from Bacillus licheniformis, Type XII-A, saline solution, ≥500 units/mg protein (biuret)
Sigma-Aldrich
αα-amilasa from Bacillus sp., Type II-A, lyophilized powder, ≥1,500 units/mg protein (biuret)
Sigma-Aldrich
αα-Amilasa from human saliva, Type IX-A, lyophilized powder, 1,000-3,000 units/mg protein
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~50 U/mg
Sigma-Aldrich
αα-Amilasa from Bacillus licheniformis, lyophilized powder, 500-1,500 units/mg protein, 93-100% (SDS-PAGE)
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, powder, ~1.5 U/mg (~0.2 U acc. to Willstätter)
Sigma-Aldrich
α-Amylase from Bacillus sp., liquid
Sigma-Aldrich
α-Amylase from porcine pancreas, PMSF Treated, Type I-A, saline suspension, ≥1000 units/mg protein (E1%/280)
Sigma-Aldrich
αα-amilasa from Bacillus sp., powder, ≥400 units/mg protein (Lowry)
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, aqueous solution, ≥800 FAU/g
Sigma-Aldrich
α-Amylase from Bacillus amyloliquefaciens, liquid, ≥250 units/g
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~380 U/mg
Sigma-Aldrich
α-Amylase from porcine pancreas, Type I-A, PMSF treated, saline suspension, 700-1400 units/mg protein (E1%/280)
Sigma-Aldrich
Hydrocortisone, meets USP testing specifications
Supelco
Hydrocortisone, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
αα-Amilasa from Bacillus licheniformis, suitable for determination of starch (Kit STA-20)